home / stock / vlon / vlon news


VLON News and Press, Vallon Pharmaceuticals Inc. From 06/28/22

Stock Information

Company Name: Vallon Pharmaceuticals Inc.
Stock Symbol: VLON
Market: NASDAQ

Menu

VLON VLON Quote VLON Short VLON News VLON Articles VLON Message Board
Get VLON Alerts

News, Short Squeeze, Breakout and More Instantly...

VLON - Trending Penny Stocks For Your Watchlist Next Month 

3 Trending Penny Stocks That Are Popular Right Now Finding trending penny stocks to buy can be challenging. But if you put in the work, it can be worth it. Right now, there is an incredible amount of volatility in the stock market. And, when we add in trending or popular news to that, w...

VLON - Best Penny Stocks For July 2022? 5 To Watch Right Now

We’re in the final stretch of June 2022 and the last few days of the second quarter. Gross Domestic Product results for the quarter and additional CPI data are also due out before July. Whether they reveal a recession, higher inflation, or something completely different may not matte...

VLON - Vallon Pharmaceuticals to raise $3.9M in stock offering

Vallon Pharmaceuticals (NASDAQ:VLON) trades 10.5% down premarket after it entered into definitive agreements with several institutional and accredited investors for the purchase and sale in a registered direct offering of 3.7M shares at purchase price of $1.0632/share. The closing o...

VLON - Vallon Pharmaceuticals Announces $3.9 Million Registered Direct Offering

PHILADELPHIA, PA, May 13, 2022 (GLOBE NEWSWIRE) -- Vallon Pharmaceuticals, Inc. (NASDAQ: VLON), (“Vallon” or the “Company”), a clinical-stage biopharmaceutical company primarily focused on the development of novel drugs that are designed to deter abuse in the...

VLON - Vallon Pharmaceuticals Reports Additional Pharmacokinetic and Pharmacodynamic Data from SEAL Study of ADAIR

PHILADELPHIA, PA, May 12, 2022 (GLOBE NEWSWIRE) -- Vallon Pharmaceuticals, Inc. (NASDAQ: VLON), (“Vallon” or the “Company”), a clinical-stage biopharmaceutical company primarily focused on the development of novel drugs that are designed to deter abuse in the...

VLON - Vallon Pharmaceuticals Announces Issuance of Japanese Patent Covering Composition of Matter and Methods of Manufacturing for ADAIR

PHILADELPHIA, PA, May 11, 2022 (GLOBE NEWSWIRE) -- Vallon Pharmaceuticals, Inc. (NASDAQ: VLON), (“Vallon” or the “Company”), a clinical-stage biopharmaceutical company primarily focused on the development of novel drugs that are designed to deter abuse in the...

VLON - Vallon Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update

PHILADELPHIA, PA, May 09, 2022 (GLOBE NEWSWIRE) -- Vallon Pharmaceuticals, Inc. (NASDAQ: VLON), (“Vallon” or the “Company”), a clinical-stage biopharmaceutical company primarily focused on the development of novel drugs that are designed to deter abuse in the...

VLON - FFIE, EVOK and ZY among mid-day movers

Gainers: Evoke Pharma (EVOK) +151%. Avadel Pharmaceuticals (AVDL) +26%. Arch Resources (ARCH) +21%. Magnachip Semiconductor (MX) +20%. TradeUP Global (TUGCU) +20%. Jiuzi Holdings (JZXN) +19%. Forge Global Holdings (FRGE) +18%. Morphic Holding (MORF) +16%. Flexsteel Industries (FLXS) +15%. Sky...

VLON - Nkarta, ERYTECH Pharma top healthcare gainers; Eliem, Clarus lead losers' pack

Gainers: Nkarta (NKTX) +84%. ERYTECH Pharma (ERYP) +54%. Sunshine Biopharma (SBFM) +25%. Rubius Therapeutics (RUBY) +17%. Quoin Pharmaceuticals (QNRX) +12%. Losers: Eliem Therapeutics (ELYM) -55%. Clarus Therapeutics Holdings (CRXT) -54%....

VLON - Vallon surges after announcing strategic review process

The shares of nano-cap stock Vallon Pharmaceuticals (NASDAQ:VLON) are trading sharply higher on Friday after the Pennsylvania-based biopharma company said it engaged Ladenburg Thalmann & Co. to advise on strategic alternatives for the firm. The strategic review will include the evaluation...

Previous 10 Next 10